Nasdaq (RTTNews.com) - Akers Biosciences, Inc. (AKER, AKR.L), a manufacturer of rapid diagnostic screening and testing products, Thursday said it has entered into multi-...
Scientific American For the past 20 years pregnant women with an increased risk of developing blood clots have often been prescribed a common blood thinner to prevent se...
The Biological SCENE The blood-thinning drug heparin has a similar chemical structure to the sugar polymer and can attract merozoites. But heparin doesn't circulate long enough in the bloodstream to be effective, and giving an anticoagulant to patients in a fragile state ...
Medscape SAN FRANCISCO — The low-molecular-weight heparin (LMWH) tinzaparin (Innohep, LEO Pharma) is better than warfarin at preventing the recurrence of blood clots in a mix of cancer patients, but not significantly so. The finding comes from the CATCH trial ...
Virtual-Strategy Magazine (press release) THOROFARE, N.J., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the receipt of an initial ...
tce today Rather than heparan sulphate, they decided to use the structurally very similar heparin , which is commercially available and has been shown to have the same binding effect on the malaria parasite. They made a biocompatible block copolymer containing ...
Digital Journal Most up-to-date research on "China Heparin Industry Report, 2014-2017" to its huge collection of research reports. Albany, NY -- (ReleaseWire) -- 12/12/2014 -- As the world's major heparin API producer and exporter, China boasts enormous raw materials, ...
The Pharmaceutical Journal The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for heparin sodium IV flush solution 100 IU/ml distributed by Kent Pharmaceuticals Ltd on behalf of Fannin (UK) Limited. This is due to an error on cartons ...
HealthCanal.com By Amanda Boundris - McMaster researchers have found new evidence that suggests patients with a history of adverse reaction to the blood thinner heparin may be ready for urgent heart surgery sooner, with a combination of appropriate blood screenings ...
